Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2012

Scale-up and manufacturing of clinical-grade self-inactivating γ-retroviral vectors by transient transfection.

Gene therapy·2011

See all related articles

Related Experiment Videos

Is Wiskott--Aldrich syndrome a cell trafficking disorder?

Related Concept Videos

Long-term safety and efficacy of lentiviral hematopoietic stem/progenitor cell gene therapy for Wiskott-Aldrich syndrome.

Molecular Evidence of Genome Editing in a Mouse Model of Immunodeficiency.

Current progress on gene therapy for primary immunodeficiencies.

Critical variables affecting clinical-grade production of the self-inactivating gamma-retroviral vector for the treatment of X-linked severe combined immunodeficiency.

Lack of T-cell responses following autologous tumour lysate pulsed dendritic cell vaccination, in patients with relapsed osteosarcoma.

Scale-up and manufacturing of clinical-grade self-inactivating γ-retroviral vectors by transient transfection.

The origin and significance of anti-DNA antibodies.

Mutations of class II MHC molecules.

Antigen processing at the molecular level.

Phenotypically and functionally distinct T-cell subsets in anti-tumor responses.

Are MHC class II-restricted cytotoxic T lymphocytes important?

Complement and the regulation of humoral immune responses.

Related Experiment Videos

Is Wiskott--Aldrich syndrome a cell trafficking disorder?

Related Concept Videos

Related Articles